Compare GPI & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPI | WGS |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.6B |
| IPO Year | 1997 | N/A |
| Metric | GPI | WGS |
|---|---|---|
| Price | $405.54 | $158.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $478.88 | $130.63 |
| AVG Volume (30 Days) | 172.7K | ★ 490.6K |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 28.66 | 0.07 |
| Revenue | ★ $22,537,600,000.00 | $402,190,000.00 |
| Revenue This Year | $14.81 | $41.17 |
| Revenue Next Year | $3.33 | $23.53 |
| P/E Ratio | ★ $14.10 | $2,161.57 |
| Revenue Growth | 19.45 | ★ 50.50 |
| 52 Week Low | $355.91 | $55.17 |
| 52 Week High | $490.09 | $170.87 |
| Indicator | GPI | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 62.52 |
| Support Level | $390.85 | $158.15 |
| Resistance Level | $412.99 | $170.87 |
| Average True Range (ATR) | 10.36 | 8.35 |
| MACD | 2.86 | 0.80 |
| Stochastic Oscillator | 63.56 | 72.69 |
Group 1 owns and operates 39 collision centers and 260 automotive dealerships in the US and the UK, offering 35 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 33.5% of new-vehicle unit volume in 2024 and the UK 22.6%. Texas, Massachusetts, and California combined was 48.5%. Revenue in 2024 totaled $19.9 billion. The August 2024 Inchcape UK deal adds about $2.7 billion of annual revenue and 54 stores. The firm entered the UK in 2007 and has 116 stores and about one-third of its new vehicle unit volume there. Group 1 was founded in 1995 and is based in Houston.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.